| 证券代码：603810 | 证券简称：丰山集团 | 公告编号：2023-080 | | --- | --- | --- | | 转债代码：113649 | 转债简称：丰山转债 | | 江苏丰山集团股份有限公司 江苏丰山集团股份有限公司（以下简称"公司"）第三届监事会第二十四次 会议通知于 2023 年 10 月 23 日以邮件、通讯方式发出，会议于 2023 年 10 月 28 日以通讯表决的方式召开。本次会议应出席监事 3 名，实际 3 名监事出席会议， 会议由监事会主席缪永国先生主持。本次会议的召集、召开及表决程序符合《公 司法》及《公司章程》、《监事会议事规则》等法律、法规、规范性文件的规定。 二、监事会会议审议情况 （一）审议通过《公司 2023 年第三季度报告》； 监事会意见：经审核，监事会认为董事会编制和审核公司 2023 年第三季度 报告的程序符合法律、行政法规和中国证监会的规定，报告内容真实、准确、 完整地反映了公司的实际情况，不存在任何虚假记载、误导性陈述或者重大遗 漏。 具体内容详见公司于同日在指定信息披露媒体披露的《公司 2023 年第三季 度报告》。 江苏丰山集团股份有限公司监事会 ...

未转股可转债情况：截至 2023 年 9 月 30 日，尚未转股的"丰山转债"金 额为人民币 499,350,000 元，占"丰山转债"发行总额的 99.87%。 本季度转股情况：本季度，"丰山转债"转股金额为 5,000 元，因转股 形成的股份数量为 363 股。 一、可转债发行上市概况 经中国证券监督管理委员会证监许可[2022]961 号核准，江苏丰山集团股份 有限公司（以下简称"公司"）于 2022 年 6 月 27 日公开发行了 500 万张可转换 公司债券，每张面值 100 元，发行总额 50,000.00 万元。本次发行的可转债期限 为自发行之日起 6 年，自 2022 年 6 月 27 日至 2028 年 6 月 26 日，票面利率为第 一年 0.3%、第二年 0.6%、第三年 1.0%、第四年 1.5%、第五年 2.0%、第六年 3.0%。 | 证券代码：603810 | 证券简称：丰山集团 | 公告编号：2023-077 | | --- | --- | --- | | 转债代码：113649 | 转债简称：丰山转债 | | 江苏丰山集团股份有限公司 关于可转债转股结果暨股份变动的公告 本公 ...

| 证券代码：603810 | 证券简称：丰山集团 | 公告编号：2023-076 | | --- | --- | --- | | 转债代码：113649 | 转债简称：丰山转债 | | 江苏丰山集团股份有限公司 关于2023年半年度业绩说明会召开情况的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 江苏丰山集团股份有限公司（以下简称"公司"）于 2023 年 9 月 12 日（星 期二）上午 10:00-11:00 通过"价值在线"（www.ir-online.cn）以网络互动的方式 召开了 2023 年半年度业绩说明会。现将有关事项公告如下： 问题 1：公司目前在投项目有哪些？进展如何？ 答：尊敬的投资者您好，感谢您的关注。公司在投项目及进展情况请查阅公 司于 2023 年 8 月 31 日在指定信息披露媒体披露的《2023 年半年度报告》《关 于 2023 年半年度募集资金存放与使用情况的专项报告》，并关注公司后续披露 的相关项目进展公告。 问题 2：你们公司钠离子电解液项目投产情况怎么样了？ 答：尊敬的投资者您好 ...

致：江苏丰山集团股份有限公司 江苏众连晟律师事务所（以下简称"本所"）接受江苏丰山集团股份有限 公司（以下简称"公司"）委托，担任公司 2019 年度限制性股票激励计划（以 下简称"本次股权激励计划"）的专项法律顾问。根据《上市公司股权激励管 理办法》（以下简称"《管理办法》"）、《上海证券交易所股票上市规则》 （以下简称"《上市规则》"）以及《江苏丰山集团股份有限公司 2019 年限制 性股票激励计划（草案）》（以下简称"《激励计划（草案）》"）的规定， 就公司本次回购注销部分已授予但尚未解除限售限制性股票的事项出具本法 律意见书。 江苏众连晟律师事务所 关于江苏丰山集团股份有限公司回购注销部分 已授予但尚未解除限售限制性股票的 法 律 意 见 书 众律证[2023]0911 号 为出具本法律意见书，本所律师特作如下声明： 一、本所及经办律师依据法律、法规、规范性文件等相关规定及本法律意 见书出具日以前已经发生或者存在的事实，遵循了勤勉尽责和诚实信用原则， 对公司本次部分限制性股票回购注销事项进行了充分的核查验证，保证本法律 意见书不存在虚假记载、误导性陈述及重大遗漏。 二、本所同意将本法律意见书作为公司本 ...

| 证券代码：603810 | 证券简称：丰山集团 | 公告编号：2023-074 | | --- | --- | --- | | 转债代码：113649 | 转债简称：丰山转债 | | 江苏丰山集团股份有限公司 关于股权激励限制性股票回购注销实施公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： ●回购注销原因：根据《上市公司股权激励管理办法》（以下简称"《管理办 法》"）、《江苏丰山集团股份有限公司 2019 年限制性股票激励计划（草案）》 （以下简称"《激励计划（草案）》"）等相关规定，江苏丰山集团股份有限公司 （以下简称"公司"或"丰山集团"）2019 年限制性股票激励计划（以下简称"本 次激励计划"）1 名激励对象已不符合激励条件，其已获授但尚未解锁的限制性 股票不得解锁，公司决定对该激励对象已获授但尚未解锁的 5,880 股限制性股票 进行回购注销。 ●本次注销股份的有关情况 | 回购股份数量 | 注销股份数量 | | 注销日期 | | | | | | --- | --- | --- | --- ...

| 证券代码：603810 | 证券简称：丰山集团 | 公告编号：2023-075 | | --- | --- | --- | | 转债代码：113649 | 转债简称：丰山转债 | | 江苏丰山集团股份有限公司 关于限制性股票回购注销不调整可转债转股价格的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 经中国证券监督管理委员会证监许可[2022]961 号核准，江苏丰山集团股份 有限公司（以下简称"公司"）于 2022 年 6 月 27 日公开发行了 500 万张可转 换公司债券，每张面值 100 元，发行总额 50,000.00 万元。经上海证券交易所自 律监管决定书[2022]193 号文同意，公司 50,000.00 万元可转换公司债券于 2022 年 7 月 21 日起在上海证券交易所挂牌交易，债券简称"丰山转债"，债券代码 "113649"。 "丰山转债"期限 6 年，自 2022 年 6 月 27 日至 2028 年 6 月 26 日，转股 的起止日期为 2023 年 1 月 3 日至 2028 年 6 月 ...

Financial Performance - The company's operating revenue for the first half of 2023 was approximately ¥710.49 million, a decrease of 30.17% compared to ¥1,017.46 million in the same period last year[18]. - The net profit attributable to shareholders for the first half of 2023 was approximately ¥17.37 million, down 76.61% from ¥74.25 million in the previous year[18]. - The basic earnings per share for the first half of 2023 was ¥0.11, a decline of 76.09% compared to ¥0.46 in the same period last year[19]. - The net cash flow from operating activities was negative at approximately -¥70.47 million, a significant decrease from ¥14.85 million in the previous year, representing a decline of 574.71%[18]. - The total assets at the end of the reporting period were approximately ¥2.66 billion, a slight decrease of 0.40% from ¥2.67 billion at the end of the previous year[19]. - The net assets attributable to shareholders increased by 1.41% to approximately ¥1.62 billion from ¥1.60 billion at the end of the previous year[19]. - The weighted average return on net assets for the first half of 2023 was 1.08%, down from 5.13% in the same period last year, indicating a decline of 4.05%[19]. - The company reported a revenue of ¥710,486,957.94 for the current period, a decrease of 30.17% compared to ¥1,017,464,989.35 in the previous year[36]. - The operating costs decreased by 27.79% to ¥614,427,337.30 from ¥850,858,874.28 year-on-year[36]. - The company reported a net profit of 1,883.89 million RMB for the subsidiary Jiangsu Fengshan Biochemical Technology, significantly impacting the consolidated profit[48]. Investments and Projects - The company established a subsidiary, Jiangsu Fengshan Quannuo New Energy Technology Co., Ltd., to invest in a battery electrolyte project with a planned annual production capacity of 100,000 tons, with the first phase of 50,000 tons nearing completion[30]. - The company is developing a new material production base with an annual capacity of 130,000 tons of para-chlorotoluene, in collaboration with the Yichang High-tech Zone Management Committee[30]. - The company has initiated a project to produce 3,000 tons of green grass herbicide, which has completed trial production and is now in normal production[31]. - The company has established two subsidiaries in 2022 to expand into high-end fine chemical materials and electronic chemical products, with ongoing construction projects[25]. - The company has invested in advanced environmental protection facilities, achieving significant reductions in waste emissions and earning recognition as a leading environmentally friendly enterprise[26]. Research and Development - The company has established several research and development platforms, including a provincial technology center, to enhance its innovation capabilities[28]. - The company is committed to enhancing R&D investment to achieve product differentiation and improve competitiveness[50]. - Investment in R&D increased by 40% in 2023, focusing on innovative technologies to enhance product offerings[57]. - The company reported a significant increase in research and development expenses, totaling CNY 21,723,160.83 for the first half of 2023[145]. Environmental Initiatives - The company has upgraded its wastewater treatment facilities, increasing processing capacity to 4800 m³/d, improving overall efficiency[64]. - The company has implemented real-time monitoring systems for wastewater discharge, ensuring compliance with environmental standards[64]. - The company has constructed a rotary kiln with a daily processing capacity of 25 tons for hazardous waste, and a 36t/d waste salt incineration furnace, effectively converting hazardous waste into industrial salt that meets national standards[66]. - The company has received environmental impact assessment approvals for multiple projects, including a production line with an annual capacity of 1,000 tons of a specific pesticide and 20,000 tons of pesticide formulations[67]. - The company has been recognized as an "Advanced Environmental Protection Enterprise" in Jiangsu Province, reflecting its commitment to environmental responsibility[72]. Market Expansion and Strategy - The company is expanding its market presence in Southeast Asia, targeting a 20% market share by the end of 2024[57]. - The company plans to enhance its capital operations in 2023 by leveraging its public financing platform and exploring new business development models through equity participation and acquisitions[34]. - The company is considering strategic acquisitions to bolster its market position, with a budget of up to 500 million RMB allocated for potential deals[75]. - A new marketing strategy has been implemented, focusing on digital channels, which is expected to increase customer engagement by 30%[76]. Financial Stability and Shareholder Commitments - The company has maintained a clean record regarding compliance and has not faced any penalties or corrective actions during the reporting period[94]. - The company commits to adhering to regulations regarding shareholder shareholding and changes, ensuring compliance with relevant laws and rules[84]. - Shareholder commitments include a promise to maintain dividend payouts, with an expected total of 100 million RMB in dividends for the fiscal year[78]. - The company has a stable and sufficient cash arrangement to meet future obligations related to convertible bonds[131]. Risks and Challenges - The company faces risks related to raw material supply and price fluctuations, which could impact production and operational costs[50]. - The macroeconomic environment poses risks, with potential impacts on demand and competition in the fine chemical industry[50]. - Export business is subject to strict international trade regulations, which may affect sales and operational performance[51]. Compliance and Governance - The company has not reported any changes in accounting policies or prior period error corrections for the current period[173]. - The company’s financial statements are prepared in accordance with the enterprise accounting standards, ensuring a true and complete reflection of its financial status[191]. - The company has a continuous operating assumption, indicating no significant factors affecting its ability to continue operations within the next 12 months[189].

江苏丰山集团股份有限公司 关于举办2023年半年度业绩说明会的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 | 证券代码：603810 | 证券简称：丰山集团 公告编号：2023-073 | | --- | --- | | 转债代码：113649 | 转债简称：丰山转债 | 重要内容提示： 一、说明会类型 江苏丰山集团股份有限公司（以下简称"公司"）已于 2023 年 8 月 31 日在 上海证券交易所网站（www.sse.com.cn）披露了《2023 年半年度报告全文》及《2023 年半年度报告摘要》。为便于广大投资者更加全面深入地了解公司经营业绩、发 会议召开时间：2023 年 09 月 12 日（星期二）10:00-11:00 会议召开地点：价值在线（www.ir-online.cn） 会议召开方式：网络互动方式 会议问题征集： 投 资 者 可 于 2023 年 09 月 12 日 前 访 问 网 址 https://eseb.cn/17zmRBerPr2 或使用微信扫描下方小程序码进行会前提 问，公司将通过本 ...

会议召开时间：2023 年 05 月 15 日（星期一）10:00-11:00 会议召开地点：价值在线（www.ir-online.cn） 会议召开方式：网络互动方式 会议问题征集： 投 资 者 可 于 2023 年 05 月 15 日 前 访 问 网 址 https://eseb.cn/14qBE8vPv2M 或使用微信扫描下方小程序码进行会前提 问，公司将通过本次业绩说明会，在信息披露允许范围内就投资者普遍 关注的问题进行回答。 （www.ir-online.cn）举办江苏丰山集团股份有限公司 2022 年年度业绩说明会， 与投资者进行沟通和交流，广泛听取投资者的意见和建议。 二、说明会召开的时间、地点和方式 | 证券代码：603810 | 证券简称：丰山集团 | 公告编号：2023-044 | | --- | --- | --- | | 转债代码：113649 | 转债简称：丰山转债 | | 江苏丰山集团股份有限公司 关于举办2022年年度业绩说明会的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： ...

Financial Performance - The company's operating revenue for 2022 was CNY 1,709,170,519, representing a 12.59% increase compared to CNY 1,518,111,081 in 2021[20] - The net profit attributable to shareholders for 2022 was CNY 99,229,330.76, a decrease of 13.51% from CNY 114,725,344.99 in 2021[20] - The net profit attributable to shareholders after deducting non-recurring gains and losses was CNY 97,157,650.60, down 2.48% from CNY 99,624,503.09 in 2021[20] - Basic earnings per share decreased by 13.89% to CNY 0.62 in 2022 from CNY 0.72 in 2021[21] - Diluted earnings per share fell by 15.28% to CNY 0.61 in 2022 compared to CNY 0.72 in 2021[21] - Operating profit decreased by 23.94% to CNY 10,174,820, down from CNY 13,377,560 in the previous year[49] - The company's gross profit margin decreased by 3.4% due to a 17.35% increase in main business costs, which reached CNY 1,424,263,004[51] Cash Flow and Assets - The net cash flow from operating activities increased significantly to CNY 185,450,042.47, a 210.33% rise from CNY 59,758,888.25 in 2021[20] - The total assets of the company at the end of 2022 were CNY 2,667,197,386.94, reflecting a 33.85% increase from CNY 1,992,675,036.08 at the end of 2021[20] - The net assets attributable to shareholders increased to CNY 1,599,453,072.35, a 12.58% rise from CNY 1,420,679,028.35 in 2021[20] - The company's total financial assets increased from CNY 311.56 million at the beginning of the year to CNY 371.90 million by year-end, reflecting a change of CNY 60.34 million[29] - The company's cash and cash equivalents at the end of the period were approximately ¥705.04 million, a 93.32% increase from the previous year[67] Investments and Subsidiaries - The company established Jiangsu Fengshan Quannuo New Energy Technology Co., Ltd. in August 2022, planning to invest in a project with an annual production capacity of 100,000 tons of battery electrolyte[31] - In September 2022, the company set up Hubei Fengshan New Materials Co., Ltd. to develop high-end fine chemical materials, with a planned production capacity of 130,000 tons of para-chlorotoluene[31] - The company has established a wholly-owned subsidiary, Jiangsu Fengshan Biochemical Technology Co., Ltd., to strengthen its pesticide sector and enhance operational efficiency[32] - The company has established three new wholly-owned subsidiaries in 2022, expanding its operational scope and market presence[60] - The company holds 100% equity in Hubei Fengshan and Fengshan Biochemical, indicating a strategic focus on full ownership in new ventures[100] Research and Development - The company has established a comprehensive R&D mechanism, focusing on high-efficiency, low-toxicity, and environmentally friendly pesticide raw materials and intermediates[41] - The company’s research and development expenses increased by 12.07% to CNY 49,456,459[50] - The company has established strong R&D capabilities, with 20 authorized invention patents and 2 utility model patents as of December 31, 2022, indicating robust innovation potential[46] - The company is committed to developing high-end fine chemical products, including chlorinated and fluorinated chemicals, to enhance product competitiveness[120] Market Trends and Competition - The lithium-ion electrolyte market is expected to face intensified competition in 2023, with companies possessing cost and technological advantages likely to stand out[39] - The agricultural sector is expected to see a rise in pesticide production revenue from 228.06 billion to over 250 billion by 2025, indicating growth potential in the industry[74] - The agricultural chemical industry in China is undergoing consolidation, with government policies promoting mergers and acquisitions to increase industry concentration and competitiveness[114] - The electrolyte industry is shifting from capacity competition to R&D innovation competition, requiring manufacturers to develop new functional electrolyte solutions[119] Environmental Management - The company has made significant progress in environmental management, optimizing wastewater treatment processes to achieve high standards and low emissions[34] - The company has received multiple honors for its environmental efforts, including recognition as an advanced enterprise in environmental protection in Jiangsu Province[192] - The company has invested in pollution control facilities, enhancing the efficiency of "three wastes" treatment and reducing emissions[183] - The company has implemented a hazardous waste incineration system with a daily processing capacity of 25 tons, along with a 36 tons/day waste salt incinerator and a 60 tons/day liquid incinerator[186] Governance and Management - The company has established a governance structure consisting of the shareholders' meeting, board of directors, supervisory board, and senior management, ensuring clear responsibilities and coordinated operations[132] - The board of directors comprises 9 members, including 3 independent directors, and has established specialized committees to provide professional opinions for decision-making[134] - The company has implemented a comprehensive investor relations management system, conducting multiple online performance briefings to enhance communication with investors[136] - The company plans to continue enhancing its governance structure and investor relations management to protect shareholders' rights and improve transparency[136] Future Outlook - The company provided a future outlook, projecting a revenue growth of 20% for the next fiscal year[146] - The company plans to accelerate the construction and implementation of three major industrial sectors in 2023, ensuring timely completion and operation of projects through synchronized recruitment and market development[123] - The company aims to enhance its core competitiveness in the high-end fine chemical industry, focusing on expanding raw materials, strengthening formulations, and refining new business areas[121]